Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Dec-16 4:54 PM View:  | McManus John L President and CEO | Aeolus Pharmaceuticals Inc. (AOLS) | 28-Dec-16 | Grant | 25,000 | $0.15 | $3,750.00 | < 1% 3.74M to 3.77M | (33%) |
| 06-Mar-13 7:53 PM View: | McManus John L President and CEO | Aeolus Pharmaceuticals Inc. (AOLS) | 06-Mar-13 | Market Purchase | 10,000 | $0.35 | $3,500.00 | 14% 70.3K to 80.3K | (65%) |
| 20-Feb-13 6:05 PM View: | Krivulka Joseph J Director | Aeolus Pharmaceuticals Inc. (AOLS) | 19-Feb-13 | Purchase | 400,000 | -- | -- | 120% 333.33K to 733.33K | |
| 21-Feb-13 8:05 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 19-Feb-13 | Exercise (in-the money or at-the-money) | 59,150,000 | -- | -- | 149% 39.58M to 98.73M | |
| 21-Feb-13 8:05 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 19-Feb-13 | Market Sale | 1,793,890 | $0.33 | $591,985.00 | (2%) 98.73M to 96.93M | 62% |
| 23-May-12 7:22 PM View: | Skibsted Russell Chief Financial Officer | Aeolus Pharmaceuticals Inc. (AOLS) | 23-May-12 | Market Purchase | 7,027 | $0.24 | $1,678.05 | 70% 10.0K to 17.03K | (48%) |
| 06-Apr-12 2:12 PM View: | Krivulka Joseph J Director | Aeolus Pharmaceuticals Inc. (AOLS) | 05-Apr-12 | Market Purchase | 333,333 | $0.30 | $99,999.90 | 100% 0 to 333.33K | (59%) |
| 24-May-11 7:48 PM View: | McManus John L President and CEO | Aeolus Pharmaceuticals Inc. (AOLS) | 24-May-11 | Market Purchase | 10,300 | $0.45 | $4,641.00 | 17% 60.0K to 70.3K | (73%) |
| 19-May-11 5:05 PM View: | Skibsted Russell Chief Financial Officer | Aeolus Pharmaceuticals Inc. (AOLS) | 18-May-11 | Market Purchase | 10,000 | $0.41 | $4,150.00 | 100% 0 to 10.0K | (70%) |
| 19-May-11 5:10 PM View: | McManus John L President and CEO | Aeolus Pharmaceuticals Inc. (AOLS) | 18-May-11 | Market Purchase Duplicate | 10,000 | $0.43 | $4,300.00 | 17% 60.0K to 70.0K | (71%) |
| 19-May-11 5:05 PM View: | Skibsted Russell Chief Financial Officer | Aeolus Pharmaceuticals Inc. (AOLS) | 18-May-11 | Market Purchase | 10,000 | $0.43 | $4,300.00 | 100% 10.0K to 20.0K | (71%) |
| 19-May-11 5:10 PM View: | McManus John L President and CEO | Aeolus Pharmaceuticals Inc. (AOLS) | 18-May-11 | Market Purchase Duplicate | 10,000 | $0.43 | $4,300.00 | 20% 50.0K to 60.0K | (71%) |
| 17-Mar-11 5:54 PM View: | Efficacy Capital, Ltd. 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 16-Mar-11 | Market Sale | 3,799,380 | $0.61 | $2,317,620.00 | (47%) 8.15M to 4.35M | 80% |
| 17-Mar-11 5:54 PM View: | Efficacy Capital, Ltd. 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 15-Mar-11 | Market Sale | 193,234 | $0.76 | $146,858.00 | (2%) 8.34M to 8.15M | 84% |
| 15-Mar-11 4:00 PM View: | McManus John L President and CEO | Aeolus Pharmaceuticals Inc. (AOLS) | 15-Mar-11 | Market Purchase | 10,000 | $0.74 | $7,414.00 | 25% 40.0K to 50.0K | (84%) |
| 18-Feb-11 7:17 PM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 16-Feb-11 | Disposition (other) | 882,488 | -- | -- | (2%) 40.63M to 39.75M | |
| 18-Feb-11 7:18 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 16-Feb-11 | Disposition (other) Duplicate | 882,488 | -- | -- | (2%) 40.46M to 39.58M | |
| 17-Feb-11 7:53 PM View: | Efficacy Capital, Ltd. 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 16-Feb-11 | Market Sale | 57,600 | $0.97 | $55,872.00 | (< 1%) 8.4M to 8.34M | 88% |
| 17-Feb-11 7:53 PM View: | Efficacy Capital, Ltd. 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 15-Feb-11 | Market Sale | 7,000 | $0.95 | $6,650.00 | (< 1%) 8.41M to 8.4M | 87% |
| 10-Feb-11 2:02 PM View: | Efficacy Capital, Ltd. 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 08-Feb-11 | Disposition (other) | 776,904 | -- | -- | (8%) 9.18M to 8.41M | |
| 10-Feb-11 2:02 PM View: | Efficacy Capital, Ltd. 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 06-Jan-11 | Disposition (other) | 616,450 | -- | -- | (6%) 9.8M to 9.18M | |
| 18-Feb-11 7:15 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 28-Dec-10 | Exercise (in-the money or at-the-money) Duplicate | 2,500,000 | -- | -- | 7% 37.96M to 40.46M | |
| 18-Feb-11 7:11 PM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 28-Dec-10 | Exercise (in-the money or at-the-money) | 2,500,000 | -- | -- | 7% 38.13M to 40.63M | |
| 16-Aug-10 1:15 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 11-Aug-10 | Purchase | 2,500,000 | -- | -- | 8% 31.92M to 34.42M | |
| 16-Aug-10 1:18 PM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 11-Aug-10 | Purchase Duplicate | 2,500,000 | -- | -- | 8% 31.92M to 34.42M | |
| 03-Aug-10 9:10 PM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 30-Jul-10 | Acquisition (other) Duplicate | 5,892,860 | $0.28 | $1,650,000.00 | 23% 26.02M to 31.92M | |
| 03-Aug-10 9:04 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 30-Jul-10 | Acquisition (other) | 5,892,860 | $0.28 | $1,650,000.00 | 23% 26.02M to 31.92M | |
| 22-Apr-10 2:00 PM View: | McManus John L President and CEO | Aeolus Pharmaceuticals Inc. (AOLS) | 15-Apr-10 | Market Purchase | 10,000 | $0.40 | $4,000.00 | 33% 30.0K to 40.0K | (66%) |
| 28-Dec-09 1:17 PM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 24-Dec-09 | Acquisition (other) Duplicate | 714,286 | -- | -- | 3% 25.24M to 25.95M | |
| 28-Dec-09 1:01 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 24-Dec-09 | Acquisition (other) | 714,286 | -- | -- | 3% 25.24M to 25.95M | |
| 20-Oct-09 9:58 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 06-Oct-09 | Private Purchase | 5,892,860 | $0.28 | $1,650,000.00 | 13% 44.55M to 50.44M | |
| 21-Oct-09 10:54 AM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 06-Oct-09 | Private Purchase Duplicate | 5,892,860 | $0.28 | $1,650,000.00 | 13% 44.55M to 50.44M | |
| 21-Oct-09 10:54 AM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 06-Oct-09 | Acquisition (other) Duplicate | 36,993 | $0.35 | $12,847.70 | < 1% 44.51M to 44.55M | |
| 20-Oct-09 9:58 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 06-Oct-09 | Acquisition (other) | 36,993 | $0.35 | $12,847.70 | < 1% 44.51M to 44.55M | |
| 21-Oct-09 10:54 AM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 06-Oct-09 | Conversion Duplicate | 2,857,140 | $0.35 | $1,000,000.00 | 7% 41.65M to 44.51M | |
| 20-Oct-09 9:58 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 06-Oct-09 | Conversion | 2,857,140 | $0.35 | $1,000,000.00 | 7% 41.65M to 44.51M | |
| 21-Oct-09 10:54 AM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 31-Jul-09 | Acquisition (other) Duplicate | 95,537 | $0.36 | $34,708.60 | < 1% 41.56M to 41.65M | |
| 20-Oct-09 9:58 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 31-Jul-09 | Acquisition (other) | 95,537 | $0.36 | $34,708.60 | < 1% 41.56M to 41.65M | |
| 20-Oct-09 9:58 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 22-Apr-09 | Market Purchase | 20,000 | $0.39 | $7,800.00 | < 1% 41.54M to 41.56M | (69%) |
| 21-Oct-09 10:54 AM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 22-Apr-09 | Market Purchase Duplicate | 20,000 | $0.39 | $7,800.00 | < 1% 41.54M to 41.56M | (69%) |
| 20-Oct-09 9:58 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 02-Apr-09 | Market Purchase | 20,000 | $0.39 | $7,850.00 | < 1% 41.52M to 41.54M | (69%) |
| 21-Oct-09 10:54 AM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 02-Apr-09 | Market Purchase Duplicate | 20,000 | $0.39 | $7,850.00 | < 1% 41.52M to 41.54M | (69%) |
| 02-Apr-09 2:09 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 30-Mar-09 | Private Purchase | 5,357,140 | $0.28 | $1,500,000.00 | 25% 21.66M to 27.02M | 18% |
| 02-Apr-09 2:30 PM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 30-Mar-09 | Private Purchase Duplicate | 5,357,140 | $0.28 | $1,500,000.00 | 25% 21.66M to 27.02M | 18% |
| 02-Apr-09 2:09 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 31-Jan-09 | Purchase | 79,838 | $0.35 | $27,783.60 | < 1% 21.58M to 21.66M | 99% |
| 02-Apr-09 2:30 PM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 31-Jan-09 | Purchase Duplicate | 79,838 | $0.35 | $27,783.60 | < 1% 21.58M to 21.66M | 99% |
| 31-Dec-08 1:59 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 30-Dec-08 | Market Purchase | 10,000 | $0.32 | $3,200.00 | < 1% 21.48M to 21.49M | (27%) |
| 31-Dec-08 3:16 PM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 30-Dec-08 | Market Purchase Duplicate | 10,000 | $0.32 | $3,200.00 | < 1% 21.48M to 21.49M | (27%) |
| 31-Dec-08 1:59 PM View: | Xmark Opportunity Partners,... 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 29-Dec-08 | Acquisition (small) | 5,000 | $0.39 | $1,950.00 | < 1% 21.47M to 21.48M | (40%) |
| 31-Dec-08 3:16 PM View: | Cavalier David Director 10% Owner | Aeolus Pharmaceuticals Inc. (AOLS) | 29-Dec-08 | Acquisition (small) Duplicate | 5,000 | $0.39 | $1,950.00 | < 1% 21.47M to 21.48M | (40%) |
